Description
The Owen Mumford Neuropen is a pocket sized screening device that combines both neuropathy tests in one tool, a 10g monofilament pressure test for large nerve fibers and a 40g Neurotip sharpness test for small nerve fibers. The manufacturer describes it as the only peripheral neuropathy screening device that combines pressure and sharpness testing in a single unit.
- Two Tests, One Device – Pressure and sharpness screening cover both large and small fiber function without carrying separate instruments.
- Pocket Format – The compact reusable device fits clinic rounds, home visits and community screening events.
- Diabetic Foot Focus – The tool is built for the foot screening programs that catch neuropathy before ulcers develop.
About This Neuropen Screening Device
Diabetic peripheral neuropathy is one of the most common complications of diabetes and drives foot ulcers and amputations that early detection can help prevent. Screening cannot rule neuropathy out on symptoms alone, so regular foot screening with instruments is the standard the manufacturer designs for. Neuropen sets that standard in one device, testing protective pressure sensation with the 10g monofilament and pain sharpness with the single use Neurotip.
The device is reusable, with replacement monofilaments and Neurotips available in the same range. Healthcare professionals use it to identify areas of reduced sensitivity during routine diabetic foot assessments. Its dual purpose design makes it a first of its kind pocket device for safe and reliable testing, per the manufacturer.
Features and Benefits
Screening Capability
- 10g Pressure Test – The calibrated monofilament applies a consistent, repeatable force to identify reduced pressure sensitivity.
- 40g Sharpness Test – Single use Neurotips assess reduced sensitivity to sharpness or pain in small nerve fibers.
Clinical Use
- Reusable Platform – The device body is reusable while filaments and pins are replaced as consumables.
- Program Ready – Precise, repeatable assessments support structured diabetes care and foot screening programs.
Product Specifications
Product Details
- Manufacturer: Owen Mumford
- Product Type: Peripheral neuropathy screening device
- Tests: 10g monofilament pressure test and 40g Neurotip sharpness test
- Device Format: Reusable, pocket sized
- Consumables: Neuropen Monofilaments and Neurotips, sold separately
- Intended Use: Professional screening of diabetic peripheral neuropathy in the foot
Packaging
- Options: One device per pack
- Storage: Store at room temperature
Browse related categories: diabetic foot care and Owen Mumford products.
Why Choose This Screening Device
Foot screening programs stall when the two standard tests live in two different kits that are never in the same room. One pocket device carrying both tests removes that excuse and makes every assessment complete.
- Complete Assessments – Large and small fiber screening in a single visit catches more neuropathy earlier.
- Program Consistency – Calibrated, repeatable forces make results comparable across staff and sites.
- Only Dual Test Device – The manufacturer positions Neuropen as the only device combining both tests, a differentiator over separate monofilament and pin tools.
Manuals and Troubleshooting Guides
Frequently Asked Questions
What two tests does the device perform?
A 10g pressure test with the monofilament checks for decreased pressure sensation. A 40g sharpness test with a Neurotip checks small fiber sensitivity to sharpness and pain.
Why screen both fiber types?
Large and small nerve fibers fail differently as neuropathy progresses. Testing both gives a fuller picture of foot risk than either test alone.
Is the device reusable?
Yes, the device is reusable. Monofilaments and Neurotips are the replaceable consumables in the range.
Who performs the screening?
Healthcare professionals run the tests during diabetic foot screening. The device is designed for professional assessment, not self-testing.
What do abnormal results mean?
Reduced pressure or sharpness sensitivity at a site flags an area for clinical follow up under the local diabetes care pathway. The screening supports, and does not replace, full clinical evaluation.
Does it come with consumables?
This listing is the Neuropen device itself. Replacement monofilaments and Neurotips are listed separately in the same range.
